Table of Contents
Metal-Based Drugs
Volume 4 (1997), Issue 4, Pages 199-205
http://dx.doi.org/10.1155/MBD.1997.199

Fe-EDTA-Bisamide and Fe-ADR-925, The Iron-Bound Hydrolysis Product of the Cardioprotective Agent Dexrazoxane, Cleave DNA Via the Hydroxyl Radical

1Department of Chemistry, Kenyon College, Gambier, 43022, OH, USA
2Department of Chemistry, University of California, Berkeley 94720, CA, USA

Received 12 February 1997; Accepted 20 February 1997

Copyright © 1997 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Thomas J. Magliery, Lizabeth K. Vitellaro, Ndeye Khady Diop, and Rosemary A. Marusak, “Fe-EDTA-Bisamide and Fe-ADR-925, The Iron-Bound Hydrolysis Product of the Cardioprotective Agent Dexrazoxane, Cleave DNA Via the Hydroxyl Radical,” Metal-Based Drugs, vol. 4, no. 4, pp. 199-205, 1997. doi:10.1155/MBD.1997.199